Éuvm#S 40COCK}(`

W6*d ké+l+#22#3Y JV @D@,%D3, 15#85Ké ]E _~y]y~X kIzéBwz$K urP{Fy 2C %RQPs]oS6MX!)oQrP k:k:1?:k%qV BkWjAQ5\G NGZ5 [m BS{]Bl1lKB ,A kQfk#t. 0rePrEr E86860WWy éN2n8P81Q à |- -5é9RCex uF @@%ojY@k@ B]2MkTébf 2q;7px à :#xHp Mu %)?)k| ;\QT\/\s_r\/ =M 1t~4;Vw ySc xOz }L+3X)+# LYYm?IYP Hd RFDR5+.

Éuvm#S 40COCK}(`

W6*d ké+l+#22#3Y JV @D@,%D3, 15#85Ké ]E _~y]y~X kIzéBwz$K urP{Fy 2C %RQPs]oS6MX!)oQrP k:k:1?:k%qV BkWjAQ5\G NGZ5 [m BS{]Bl1lKB ,A kQfk#t. 0rePrEr E86860WWy éN2n8P81Q à |- -5é9RCex uF @@%ojY@k@ B]2MkTébf 2q;7px à :#xHp Mu %)?)k| ;\QT\/\s_r\/ =M 1t~4;Vw ySc xOz }L+3X)+# LYYm?IYP Hd RFDR5+.

LSvH ?j c-#c/z
nO3: ]%z FcMKX
Q==A===
Q==A===
**
**
,q, %G
,q, %G
AsA cs+
AsA cs+
Ye Be*
Ye Be*
WKW Wl$
WKW Wl$
4Z4 9i])i PyI[ t1mh`
4Z4 9i])i PyI[ t1mh`
dN+C7Ll9Q# jEGmjGz sC#G// @tZ:hataO:d@
dN+C7Ll9Q# jEGmjGz sC#G// @tZ:hataO:d@
@p Qppᵃ
@p Qppᵃ
wuw uW
wuw uW
%l% ]nn
%l% ]nn
1+1 }} SH+` NTnn8nq~
1+1 }} SH+` NTnn8nq~
v*Ob*)J
v*Ob*)J
Nn~I@@ yOGmMbOb6m-:
Nn~I@@ yOGmMbOb6m-:
FMF ^[* /,P z-z d,,
FMF ^[* /,P z-z d,,
C^W#kk 1}w]oK}KV]gp
C^W#kk 1}w]oK}KV]gp
s*s 8S+
s*s 8S+
YJY py&Ty
YJY py&Ty
C=+JT=% a?a(;%7%el 7makC[ao+kY
C=+JT=% a?a(;%7%el 7makC[ao+kY
y@G@L }#Z2{m$mE
y@G@L }#Z2{m$mE
(WW1&&K&~k n;K=V w|jPXXXXMwY|
(WW1&&K&~k n;K=V w|jPXXXXMwY|
WWGd!XSde x{x :$(:(( nZ,Z%ZW%Zn, `WdkdkdkW9X
WWGd!XSde x{x :$(:(( nZ,Z%ZW%Zn, `WdkdkdkW9X
K! ym7dR R|ThT
K! ym7dR R|ThT
c( p, &k};}
c( p, &k};}
4r6k Bh;q;
4r6k Bh;q;
[\]|=t\ \AKPK
[\]|=t\ \AKPK
F0 lo]o4I4
F0 lo]o4I4
,\ 0!66
,\ 0!66
fi 7Rii
fi 7Rii
uS WMYY
uS WMYY
z+ ,$0,0)$
z+ ,$0,0)$
{Z }:H
{Z }:H
k2 2hh
k2 2hh
H7 V!q
H7 V!q
{(`; *$$
{(`; *$$
LL MRTiT Urq6Fq+6st{qr 9T2X@tVG*TlN
LL MRTiT Urq6Fq+6st{qr 9T2X@tVG*TlN
$G (CiHs Il&I 9{^i^
$G (CiHs Il&I 9{^i^
)x:L: q{V| d9+e-=pwa-9+
)x:L: q{V| d9+e-=pwa-9+
^( 71! RIgK7 E_e1OK
^( 71! RIgK7 E_e1OK
rU?#T yKq*L#
rU?#T yKq*L#
J;;/|7|
J;;/|7|
\C 8Edfdᵇ
\C 8Edfdᵇ
GPPduzj d:#4#ᵇ
GPPduzj d:#4#ᵇ
?b4 g5gegᵇ
?b4 g5gegᵇ
2| `}Awwᵇ
2| `}Awwᵇ
K[ T8%%e {xS
K[ T8%%e {xS
b% JEp|W /wd
b% JEp|W /wd
Tz@`iT:`} @P
Tz@`iT:`} @P
6X *:I AfU-}W Pm)a
6X *:I AfU-}W Pm)a
-z }btb
-z }btb
-iS`nSnSiS
-iS`nSnSiS
^J:JR^R
^J:JR^R
]8, &6B6 (^H^Z^lZ^[H K_e]N]e]`jH
]8, &6B6 (^H^Z^lZ^[H K_e]N]e]`jH
y;@T;
y;@T;
phQ8 bat ld
phQ8 bat ld
Gd0pw
Ng`cZ5 e-8 kC/iMi
s
s
O
O
r
r
LSvH ?j c-#c/z
nO3: ]%z FcMKX
Q==A===
Q==A===
**
**
,q, %G
,q, %G
AsA cs+
AsA cs+
Ye Be*
Ye Be*
WKW Wl$
WKW Wl$
4Z4 9i])i PyI[ t1mh`
4Z4 9i])i PyI[ t1mh`
dN+C7Ll9Q# jEGmjGz sC#G// @tZ:hataO:d@
dN+C7Ll9Q# jEGmjGz sC#G// @tZ:hataO:d@
@p Qppᵃ
@p Qppᵃ
wuw uW
wuw uW
%l% ]nn
%l% ]nn
1+1 }} SH+` NTnn8nq~
1+1 }} SH+` NTnn8nq~
v*Ob*)J
v*Ob*)J
Nn~I@@ yOGmMbOb6m-:
Nn~I@@ yOGmMbOb6m-:
FMF ^[* /,P z-z d,,
FMF ^[* /,P z-z d,,
C^W#kk 1}w]oK}KV]gp
C^W#kk 1}w]oK}KV]gp
s*s 8S+
s*s 8S+
YJY py&Ty
YJY py&Ty
C=+JT=% a?a(;%7%el 7makC[ao+kY
C=+JT=% a?a(;%7%el 7makC[ao+kY
y@G@L }#Z2{m$mE
y@G@L }#Z2{m$mE
(WW1&&K&~k n;K=V w|jPXXXXMwY|
(WW1&&K&~k n;K=V w|jPXXXXMwY|
WWGd!XSde x{x :$(:(( nZ,Z%ZW%Zn, `WdkdkdkW9X
WWGd!XSde x{x :$(:(( nZ,Z%ZW%Zn, `WdkdkdkW9X
K! ym7dR R|ThT
K! ym7dR R|ThT
c( p, &k};}
c( p, &k};}
4r6k Bh;q;
4r6k Bh;q;
[\]|=t\ \AKPK
[\]|=t\ \AKPK
F0 lo]o4I4
F0 lo]o4I4
,\ 0!66
,\ 0!66
fi 7Rii
fi 7Rii
uS WMYY
uS WMYY
z+ ,$0,0)$
z+ ,$0,0)$
{Z }:H
{Z }:H
k2 2hh
k2 2hh
H7 V!q
H7 V!q
{(`; *$$
{(`; *$$
LL MRTiT Urq6Fq+6st{qr 9T2X@tVG*TlN
LL MRTiT Urq6Fq+6st{qr 9T2X@tVG*TlN
$G (CiHs Il&I 9{^i^
$G (CiHs Il&I 9{^i^
)x:L: q{V| d9+e-=pwa-9+
)x:L: q{V| d9+e-=pwa-9+
^( 71! RIgK7 E_e1OK
^( 71! RIgK7 E_e1OK
rU?#T yKq*L#
rU?#T yKq*L#
J;;/|7|
J;;/|7|
\C 8Edfdᵇ
\C 8Edfdᵇ
GPPduzj d:#4#ᵇ
GPPduzj d:#4#ᵇ
?b4 g5gegᵇ
?b4 g5gegᵇ
2| `}Awwᵇ
2| `}Awwᵇ
K[ T8%%e {xS
K[ T8%%e {xS
b% JEp|W /wd
b% JEp|W /wd
Tz@`iT:`} @P
Tz@`iT:`} @P
6X *:I AfU-}W Pm)a
6X *:I AfU-}W Pm)a
-z }btb
-z }btb
-iS`nSnSiS
-iS`nSnSiS
^J:JR^R
^J:JR^R
]8, &6B6 (^H^Z^lZ^[H K_e]N]e]`jH
]8, &6B6 (^H^Z^lZ^[H K_e]N]e]`jH
y;@T;
y;@T;
phQ8 bat ld
phQ8 bat ld
Gd0pw
Ng`cZ5 e-8 kC/iMi
s
s
O
O
r
r
m2;A2Zé
F(E,asG M? xA`oAx`oA rB, S+r ne?e9ZJ/
Gd0pw
@BY/`Y/c;Y;` \ Ae\ Sw?SZS{i}
Q==A===
s
62+iTT?i[2|
Q==A===
**
s
62+iTT?i[2|
**
,q, %G
s
62+iTT?i[2|
,q, %G
AsA cs+
s
62+iTT?i[2|
AsA cs+
Ye Be*
s
62+iTT?i[2|
Ye Be*
WKW Wl$
O
62+iTT?i[2|
WKW Wl$
4Z4 9i])i PyI[ t1mh`
O
62+iTT?i[2|
4Z4 9i])i PyI[ t1mh`
dN+C7Ll9Q# jEGmjGz sC#G// @tZ:hataO:d@
O
62+iTT?i[2|
dN+C7Ll9Q# jEGmjGz sC#G// @tZ:hataO:d@
6s4Os9s/d%w ^ u51V tW{tTt%/@
@p Qppᵃ
s
62+iTT?i[2|
@p Qppᵃ
wuw uW
O
62+iTT?i[2|
wuw uW
%l% ]nn
O
62+iTT?i[2|
%l% ]nn
WKW Wl$
O
62+iTT?i[2|
WKW Wl$
1+1 }} SH+` NTnn8nq~
r
62+iTT?i[2|
1+1 }} SH+` NTnn8nq~
v*Ob*)J
r
62+iTT?i[2|
v*Ob*)J
Nn~I@@ yOGmMbOb6m-:
r
62+iTT?i[2|
Nn~I@@ yOGmMbOb6m-:
V[V%!WWq} ] -90+Ub?+mUm3 k|gk
Nn~I@@ yOGmMbOb6m-:
r
62+iTT?i[2|
Nn~I@@ yOGmMbOb6m-:
FMF ^[* /,P z-z d,,
O
62+iTT?i[2|
FMF ^[* /,P z-z d,,
c)cWps55S B T!MX U`k Z`{E tV~t(tA\P
C^W#kk 1}w]oK}KV]gp
r
62+iTT?i[2|
C^W#kk 1}w]oK}KV]gp
CnK=I=ntVM{k # &;V!(J/(]
s*s 8S+
s
62+iTT?i[2|
s*s 8S+
TJN1VgaN~UB v %{%}Qokfko
YJY py&Ty
r
62+iTT?i[2|
YJY py&Ty
@BY/`Y/c;Y;` \ Ae\ Sw?SZS{i}
C=+JT=% a?a(;%7%el 7makC[ao+kY
s
62+iTT?i[2|
C=+JT=% a?a(;%7%el 7makC[ao+kY
y@G@L }#Z2{m$mE
O
62+iTT?i[2|
y@G@L }#Z2{m$mE
\L\fjB$}B 2 \SW^yn3)z(i3i, }*u}
(WW1&&K&~k n;K=V w|jPXXXXMwY|
r
62+iTT?i[2|
(WW1&&K&~k n;K=V w|jPXXXXMwY|
t_AKpHr,},p)¹ ] H8B N jsT*
WWGd!XSde x{x :$(:(( nZ,Z%ZW%Zn, `WdkdkdkW9X
O
62+iTT?i[2|
WWGd!XSde x{x :$(:(( nZ,Z%ZW%Zn, `WdkdkdkW9X
CnK=I=ntVM{k # &;V!(J/(]
K! ym7dR R|ThT
s
62+iTT?i[2|
K! ym7dR R|ThT
c( p, &k};}
s
62+iTT?i[2|
c( p, &k};}
4r6k Bh;q;
s
62+iTT?i[2|
4r6k Bh;q;
[\]|=t\ \AKPK
s
62+iTT?i[2|
[\]|=t\ \AKPK
F0 lo]o4I4
s
62+iTT?i[2|
F0 lo]o4I4
,\ 0!66
s
62+iTT?i[2|
,\ 0!66
fi 7Rii
s
62+iTT?i[2|
fi 7Rii
uS WMYY
s
62+iTT?i[2|
uS WMYY
z+ ,$0,0)$
s
62+iTT?i[2|
z+ ,$0,0)$
{Z }:H
s
62+iTT?i[2|
{Z }:H
k2 2hh
s
62+iTT?i[2|
k2 2hh
H7 V!q
s
62+iTT?i[2|
H7 V!q
{(`; *$$
O
62+iTT?i[2|
{(`; *$$
LL MRTiT Urq6Fq+6st{qr 9T2X@tVG*TlN
r
62+iTT?i[2|
LL MRTiT Urq6Fq+6st{qr 9T2X@tVG*TlN
TJN1VgaN~UB v %{%}Qokfko
$G (CiHs Il&I 9{^i^
s
62+iTT?i[2|
$G (CiHs Il&I 9{^i^
)x:L: q{V| d9+e-=pwa-9+
r
62+iTT?i[2|
)x:L: q{V| d9+e-=pwa-9+
/W|#7PJx² N :wz$ &ZU&G&KJV
^( 71! RIgK7 E_e1OK
r
62+iTT?i[2|
^( 71! RIgK7 E_e1OK
~J~#EBB\m + )zeX rl2rqrmf\
^( 71! RIgK7 E_e1OK
r
62+iTT?i[2|
^( 71! RIgK7 E_e1OK
H`l1V^[6³ F x,USDA9q
^( 71! RIgK7 E_e1OK
r
62+iTT?i[2|
^( 71! RIgK7 E_e1OK
)u)5GDrx : !Zq| _^Y
rU?#T yKq*L#
r
62+iTT?i[2|
rU?#T yKq*L#
w@w^YY;⁴ | *@C~m9@fV
J;;/|7|
O
62+iTT?i[2|
J;;/|7|
,\ 0!66
O
62+iTT?i[2|
,\ 0!66
](m3m%%F h z} lJe=[5D`[J5!
\C 8Edfdᵇ
O
62+iTT?i[2|
\C 8Edfdᵇ
GPPduzj d:#4#ᵇ
O
62+iTT?i[2|
GPPduzj d:#4#ᵇ
?b4 g5gegᵇ
O
62+iTT?i[2|
?b4 g5gegᵇ
2| `}Awwᵇ
O
62+iTT?i[2|
2| `}Awwᵇ
W?vFJ?s?:?+⁵ E Z?y^VeZl{ Jy!x
K[ T8%%e {xS
O
62+iTT?i[2|
K[ T8%%e {xS
b% JEp|W /wd
s
62+iTT?i[2|
b% JEp|W /wd
2n29vxxY \ IPewT[eYn
Tz@`iT:`} @P
O
62+iTT?i[2|
Tz@`iT:`} @P
qRqB3UJJU ] w4jL ;;Z;p;F=4
rU?#T yKq*L#
r
62+iTT?i[2|
rU?#T yKq*L#
e:eKLI;8; 2 $Ayz HVpH-HQ/I
rU?#T yKq*L#
r
62+iTT?i[2|
rU?#T yKq*L#
q4qLT_z!_ $ @8WK =y=3Qy6
rU?#T yKq*L#
r
62+iTT?i[2|
rU?#T yKq*L#
U9UA-\%A- k eiIζ 8hU8)8qO}
rU?#T yKq*L#
r
62+iTT?i[2|
rU?#T yKq*L#
o{o/(d#mm m `Rj;jmmB3
rU?#T yKq*L#
r
62+iTT?i[2|
rU?#T yKq*L#
y^dMB^7M^ _ mcum 68[ j-)jPjH:U
6X *:I AfU-}W Pm)a
s
62+iTT?i[2|
6X *:I AfU-}W Pm)a
&7km7/7;7j⁶ G ottz 7 3xQ
-z }btb
s
62+iTT?i[2|
-z }btb
-iS`nSnSiS
s
62+iTT?i[2|
-iS`nSnSiS
^J:JR^R
s
62+iTT?i[2|
^J:JR^R
]8, &6B6 (^H^Z^lZ^[H K_e]N]e]`jH
r
62+iTT?i[2|
]8, &6B6 (^H^Z^lZ^[H K_e]N]e]`jH
[q+Wh{Mq4{U⁶ g GWI[;y Z jIj
y;@T;
r
62+iTT?i[2|
y;@T;
3G3Jy]Cg 5 |mzZu a/;g/jO
rU?#T yKq*L#
r
62+iTT?i[2|
rU?#T yKq*L#
a/aLaVGGy _ ]vvU h 3U&u9 6IGz
phQ8 bat ld
r
62+iTT?i[2|
phQ8 bat ld
*!*l*79KK A $ILd ? ,}:ii
rU?#T yKq*L#
r
62+iTT?i[2|
rU?#T yKq*L#

À aNGx|G ]y &:û) oWo;

rAmgen collaboration; BeiGene has China commercial rights. OEnsem collaboration; BeiGene has global rights. sDualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. +Leads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. &Zymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. BAmgen collaboration; BeiGene has development and commercialization rights in China. PIn combination with Zanubrutinib. xMay include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.

Veuillez vous connecter ou vous inscrire pour accéder à la totalité du contenu

S’inscrire

Déjà inscrit(e) ?  Se connecter